Prostate Cancer News and Research

RSS
Prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than 1 million men in the United States have prostate cancer and it is the second leading cause of cancer death amongst men after lung cancer. In 2009, an estimated 192,280 new cases are expected to be diagnosed and approximately 27,360 men are expected to die from the disease. Castration-resistant prostate cancer (CRPC) is defined as prostate cancer that continues to grow despite all standard-of-care hormonal (anti-androgen) therapies. Patients with castration-resistant (also known as hormone-refractory) prostate cancer have few treatment options and a poor prognosis.
Scientist reveals the impact of mitochondria in metastatic prostate cancer

Scientist reveals the impact of mitochondria in metastatic prostate cancer

Study shows new potential target for CAR T cells to inhibit solid tumors

Study shows new potential target for CAR T cells to inhibit solid tumors

Scientists discover an effective drug development candidate from rare actinomycetes

Scientists discover an effective drug development candidate from rare actinomycetes

A new rule book for the design of therapeutic cells with improved specificity and safety

A new rule book for the design of therapeutic cells with improved specificity and safety

Attacking a protein in prostate cancer cells stops the disease spread, research finds

Attacking a protein in prostate cancer cells stops the disease spread, research finds

Novel approach accelerates cancer biomarker detection in point-of-care scenarios

Novel approach accelerates cancer biomarker detection in point-of-care scenarios

Genetic variants that predict higher blood levels of lipoprotein A linked with prostate cancer risk

Genetic variants that predict higher blood levels of lipoprotein A linked with prostate cancer risk

Targeting MAPK4 in triple-negative breast cancer may lead to improved treatments

Targeting MAPK4 in triple-negative breast cancer may lead to improved treatments

Study identifies two proteins as novel markers of aggressive prostate cancer

Study identifies two proteins as novel markers of aggressive prostate cancer

Diet-associated molecules in the gut are linked with aggressive prostate cancer

Diet-associated molecules in the gut are linked with aggressive prostate cancer

Genetic biomarker test could help personalize therapy for men with high-risk prostate cancer

Genetic biomarker test could help personalize therapy for men with high-risk prostate cancer

Scientists discover a new enzymatic complex that can halt cells from aging

Scientists discover a new enzymatic complex that can halt cells from aging

New approach to identify molecular targets for improved prostate cancer therapy

New approach to identify molecular targets for improved prostate cancer therapy

Researchers identify inhibitor that converts immune cold cancer to red hot ones

Researchers identify inhibitor that converts immune cold cancer to red hot ones

Study unravels the biomechanical, biophysical response of cancer cells to drugs

Study unravels the biomechanical, biophysical response of cancer cells to drugs

Atomic force spectroscopy probes cellular biomechanics in response to drugs in hypoxia

Atomic force spectroscopy probes cellular biomechanics in response to drugs in hypoxia

Carrying out CRISPR/Cas9 in Space

Carrying out CRISPR/Cas9 in Space

New study on genotype-phenotype associations sheds light on human complex traits, diseases

New study on genotype-phenotype associations sheds light on human complex traits, diseases

Researchers study the mechanical properties of prostate cancer cells treated with anti-cancer drugs

Researchers study the mechanical properties of prostate cancer cells treated with anti-cancer drugs

Researchers suggest new strategies for finding drugs that neutralize key enzymes

Researchers suggest new strategies for finding drugs that neutralize key enzymes